Decision-analytic modeling to assist decision making in organizational innovation: The case of shared care in hearing aid provision

Health Services Research

Volumn 43, Issue 5 P1, 2008, Pages 1662-1673

  Grutters, Janneke P C ^a,b   Joore, Manuela A ^b   Van Der Horst, Frans ^c   Stokroos, Robert J ^b   Anteunis, Lucien J C ^b  

^a MAASTRO CLINIC   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cost effectiveness analysis; Decision analytic modeling; Expected value of perfect information; Hearing aid provision; Organizational innovation; Uncertainty

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE; HEARING AID; LONG TERM CARE; PROBABILITY; RISK ASSESSMENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; AUDIOLOGY; COST-BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT TECHNIQUES; GENERAL PRACTICE; HEARING AIDS; HUMANS; MARKOV CHAINS; MEDICINE; MIDDLE AGED; ORGANIZATIONAL INNOVATION; QUALITY OF HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; REFERRAL AND CONSULTATION;

EID: 52149086120     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/j.1475-6773.2008.00872.x     Document Type: Article

References (16)

1. Briggs, A., K. Claxton M. Sculpher. 2006. Decision Modelling for Health Economic Evaluation. Oxford : Oxford University Press.
2. Buxton, M. J. 2006 Economic Evaluation and Decision Making in the UK Pharmacoeconomics 24 (11) : 1133 42.
3. Central Bureau for Statistics. 2007. "StatLine database" [accessed on May 9, 2008]. Available at
4. Claxton, K. J. Posnett. 1996 An Economic Approach to Clinical Trial Design and Research Priority-Setting Health Economics 5 (6) : 513 24.
5. Claxton, K., M. Sculpher M. Drummond. 2002 A Rational Framework for Decision Making by the National Institute for Clinical Excellence (NICE) Lancet 360 (9334) : 711 5.
6. Felli, J. C. G. B. Hazen. 1998 Sensitivity Analysis and the Expected Value of Perfect Information Medical Decision Making 18 (1) : 95 109.
7. Fenwick, E., K. Claxton M. Sculpher. 2001 Representing Uncertainty: The Role of Cost-Effectiveness Acceptability Curves Health Economics 10 (8) : 779 87.
8. Fenwick, E., K. Claxton M. Sculpher. 2008 The Value of Implementation and the Value of Information: Combined and Uneven Development Medical Decision Making 28 (1) : 21 32.
9. Grutters, J. P. C., F. Van der Horst, M. A. Joore, H. Verschuure, W. A. Dreschler L. J. C. Anteunis. 2007 Potential Barriers and Facilitators for Implementation of an Integrated Care Pathway for Hearing-Impaired Persons: An Exploratory Survey among Patients and Professionals BMC Health Services Research 7 (57).
10. Hadley, J. 2000 Better Health Care Decisions: Fulfilling the Promise of Health Services Research Health Services Research 35 (1, part 2) : 175 86.
11. Hoomans, T., A. Ament, S. Evers J. L. Severens. 2007. "Worthwhile Implementation of Evidence-Based Guidelines into Clinical Practice: How to Determine the Investment Potential for Guideline Implementation and the Value for Money of Implementation Strategies?" 6th World Congress of the International Health Economics Association (iHEA), Copenhagen, Denmark.
12. Siegel, J. E., G. W. Torrance, L. B. Russell, B. R. Luce, M. C. Weinstein M. R. Gold. 1997 Guidelines for Pharmacoeconomic Studies. Recommendations from the Panel on Cost Effectiveness in Health and Medicine. Panel on Cost Effectiveness in Health and Medicine Pharmacoeconomics 11 (2) : 159 68.
13. Swan, I. R. G. G. Browning. 1994 A Prospective Evaluation of Direct Referral to Audiology Departments for Hearing Aids Journal of Laryngology and Otology 108 (2) : 120 4.
14. van Hout, B. A., M. J. Al, G. S. Gordon F. F. Rutten. 1994 Costs, Effects and C/E-Ratios Alongside a Clinical Trial Health Economics 3 (5) : 309 19.
15. Weinstein, M. C. 2006 Recent Developments in Decision-Analytic Modelling for Economic Evaluation Pharmacoeconomics 24 (11) : 1043 53.
16. Weinstein, M. C., B. O'Brien, J. Hornberger, J. Jackson, M. Johannesson, C. McCabe B. R. Luce. 2003 Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices - Modeling Studies Value in Health 6 (1) : 9 17.